Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: The escalating prevalence of Type 2 Diabetes Mellitus (T2DM) overwhelms healthcare systems. Lifestyle interventions enhancing patient monitoring and adherence vary in efficacy, emphasizing the need to understand differential response across patient subgroups. This study aimed to segment patients with T2DM into distinct latent classes and identify characteristics associated with optimal 12-month glycated haemoglobin (HbA1c) reduction.
Methods: We prospectively recruited 1000 patients with T2DM from government-funded outpatient clinics in Singapore, aged ≥ 40-year-old with HbA1c ≥ 7.0 %. Exclusion criteria included insulin treatment and cognitive impairment. Latent class analysis was applied to 912 patients, using mHealth interventions, age, education, living arrangement, baseline HbA1c, step count, and motivation (Patient Activation Measure) as indicators. 12-Month HbA1c reduction was assessed with one-way ANOVA and pairwise T-test.
Results: Within cohort, younger patients with higher education, physical activity, and baseline HbA1c exhibited the greatest HbA1c improvement (1.14 ± 1.79 %). Younger patients with lower education, despite high baseline HbA1c, exhibited a moderately lower HbA1c improvement (0.52 ± 1.41 %).
Conclusion: Individuals with higher baseline HbA1c, education, motivation, and activity levels experienced the most significant HbA1c reductions in response to lifestyle interventions. A tailored approach to these modifiable characteristics may help patients achieve substantial 12-month HbA1c reductions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.diabres.2024.111971 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Effect of Metformin on Insulin Requirement, Glycaemic Control and Weight Gain in Type 1 Diabetes During Pregnancy-a Randomised, Placebo-Controlled Multicentre Study.
Diabetes Metab Res Rev
September 2025
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Aim: Our aim was to ascertain whether metformin can reduce insulin requirement without compromising glycaemic control during pregnancy in women with type 1 diabetes.
Methods: A total of 126 pregnant women with type 1 diabetes were recruited for a randomised, double-blind, placebo-controlled multicentre study. The primary outcome was total insulin change, defined as the difference between baseline and third trimester maximum insulin dose (IU).
Impact of transitioning from conventional blood glucose monitoring to continuous glucose monitoring on glycemic control and self-management in adults with type 2 diabetes on oral glucose-lowering medications.
Diabetes Res Clin Pract
September 2025
Health Education Department, and Department of Endocrinology and Diabetes, Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Background: Despite advances, glycemic control in people with type 2 diabetes (PwT2D) treated with oral antidiabetic medications (ADMs) often remains suboptimal. Continuous glucose monitoring (CGM) has shown promise in diabetes management, offering real-time insights into glucose trends. This study evaluates the impact of transitioning from conventional self-monitoring of blood glucose (SMBG) to CGM on glycemic outcomes and self-management in PwT2D receiving oral ADMs.
View Article and Find Full Text PDFInterest in Treatment with GLP-1 Receptor Agonists for the Management of Insufficient Weight Loss or Weight Regain After Bariatric Surgery.
Obes Surg
September 2025
Department of Minimally Invasive Digestive Surgery, Antoine Béclère Hospital, AP-HP, 157 Rue de La Porte de Trivaux, 92141 Clamart, Clamart, France.
Background: Bariatric surgery (BS) is the most effective treatment for severe obesity, but a significant proportion of patients experience insufficient weight loss (IWL) or weight regain. Glucagon-like peptide-1 receptor agonists (arGLP-1) have emerged as a promising adjunctive therapy for managing these suboptimal outcomes. This study evaluates the efficacy and safety of arGLP-1 in patients with IWL or WR after BS.
View Article and Find Full Text PDFComparison of SGLT-2i and GLP-1RA on cardiovascular and renal outcomes in elderly patients with T2DM: a single-center retrospective cohort study.
Int Urol Nephrol
September 2025
Department of Pharmacy, The Affiliated Xuzhou Children's Hospital of Xuzhou Medical University, No. 18, Sudi North Road, Quanshan District, Xuzhou City, 221000, China.
Purpose: While SGLT-2i and GLP-1RA show cardiorenal benefits, their comparative efficacy in elderly type 2 diabetes mellitus (T2DM) patients remains uncertain. This study aimed to compare SGLT-2i and GLP-1RA on cardiovascular and renal outcomes in elderly T2DM patients.
Methods: This retrospective study analyzed 1,015 propensity score-matched elderly T2DM patients (SGLT-2i group: n = 583; GLP-1RA group: n = 432).
Introduction Diabetic foot ulcers (DFUs) are a serious complication of diabetes mellitus, contributing to increased morbidity, risk of amputation, and healthcare burden. Negative pressure wound therapy (NPWT) has emerged as a cornerstone in DFU management, but the comparative effectiveness of continuous versus intermittent NPWT remains unclear. This prospective observational study compares continuous and intermittent NPWT in patients with Wagner Grade 1-2 DFUs, assessing healing time (primary outcome), infection recurrence, and amputation rates (secondary outcomes).
View Article and Find Full Text PDF